Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Imaging Radiat Sci ; 55(2): 203-211, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38431450

ABSTRACT

INTRODUCTION/BACKGROUND: This study was designed to investigate the amount of time saved and the degree of contour difficulty between the two methods of contouring, mouse/keyboard, versus touch screen/stylus in radiotherapy. METHODS: Each of 94 patients consisting of 26 breast cancer cases, 24 lymph nodes cases, 25 rectal cancer cases, and 19 heart cases has been contoured twice. One with a mouse/keyboard, and the next one with the touch screen/stylus. Three radiation oncologists participated in this study. Contouring information including measured time, estimated time spent, volume of contour performed and organ contoured are recorded. To evaluate the differences between the contouring methods, the results regarding target volume and time to completion were analyzed using two-way robust ANOVA. Ease of use and contouring difficulty were compared for differences in distribution of the response choices between the groups using Pearson chi-square test. RESULTS: In this study, 94 clinical cases were studied. The average time required for contouring with the touch screen/stylus method was half the time needed for contouring patients with the mouse/keyboard method. The reduction in the time in breast cancer cases was the highest (48.2%) and the lowest in head and neck cancer cases (32.4%). In comparing the contoured volumes, no significant difference was observed between the two methods. the mean estimated time reported by the radiation oncologist in the mouse/keyboard method was 5.6 minutes longer and, in the touch screen/stylus method, was 3.9 minutes less than the actual measured time. CONCLUSIONS: All the measured and analyzed variables show the superiority of contouring with the touch screen/stylus method and reduced the time required for patient contouring by an average of 50%.


Subject(s)
Radiotherapy Planning, Computer-Assisted , Humans , Female , Radiotherapy Planning, Computer-Assisted/methods , Time Factors , Neoplasms/radiotherapy , Breast Neoplasms/radiotherapy , Male
2.
J Gastrointest Cancer ; 50(3): 380-385, 2019 Sep.
Article in English | MEDLINE | ID: mdl-29497928

ABSTRACT

PURPOSE: Upper esophageal carcinomas are uncommon but confer a poor prognosis. However, there is scarcity of data regarding outcomes of definitive chemoradiotherapy for cervical and upper thoracic esophageal squamous cell carcinoma in Iran. METHODS: In this retrospective cohort study, we analyzed data of patients with squamous cell carcinoma of cervical and upper thoracic esophagus (at 16 to 25 cm from incisors) treated by definitive chemoradiotherapy in our institution between 2007 and 2015. The primary outcome was overall survival and secondary endpoints were predictors of overall survival. RESULTS: From 2007 to 2015, 40 patients were entered to final analysis. The mean age of patients was 59.7 ± 14.3 (range 24-85 years). Sixteen (40%) were node-positive. The median follow-up time was 15.3 months. Twenty-seven patients (67.5%) died during post treatment period. Thirty-five percent and 25% of patients suffered from local and distant recurrences, respectively. The actuarial median overall survival was 19.2 (CI 95% 14.2-24.2) months. The 1- and 2-year overall survival rates were 76 and 38%, respectively. The overall survival was higher among patients who were younger than 50 years, of female gender, had stage II tumor, grades I to II, who received induction chemotherapy, and whom treated with doses < 60 Gy. However, none of the differences was statistically significant. CONCLUSIONS: Cervical and upper thoracic esophageal squamous cell carcinomas are associated with bad outcome. Studies with bigger sample sizes are required to define best treatment strategies.


Subject(s)
Adenocarcinoma/mortality , Chemoradiotherapy/mortality , Esophageal Neoplasms/mortality , Esophageal Squamous Cell Carcinoma/mortality , Neoplasm Recurrence, Local/mortality , Rare Diseases/mortality , Thoracic Neoplasms/mortality , Adenocarcinoma/pathology , Adenocarcinoma/therapy , Adult , Aged , Aged, 80 and over , Esophageal Neoplasms/pathology , Esophageal Neoplasms/therapy , Esophageal Squamous Cell Carcinoma/pathology , Esophageal Squamous Cell Carcinoma/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/therapy , Prognosis , Rare Diseases/pathology , Rare Diseases/therapy , Retrospective Studies , Survival Rate , Thoracic Neoplasms/pathology , Thoracic Neoplasms/therapy , Young Adult
3.
J Gastrointest Cancer ; 50(4): 907-912, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30402826

ABSTRACT

PURPOSE: The optimal treatment for locally advanced GEJ and cardia adenocarcinoma is controversial. Several studies have shown that treating these patients with neoadjuvant chemoradiotherapy followed by surgery leads to survival benefits, and there are also studies that have declared conflicting results. It seems that there is still room for discussion. We calculated the survival rates and pathologic responses in our patients with characteristics which we mentioned above. METHODS: Patients with locally advanced, non-metastatic GEJ and cardia adenocarcinomas (only patients with Siewert's type I and II), who were referred to Imam Khomeini hospital (Institute of cancer) between 2005 and 2014 and received neoadjuvant chemoradiation and underwent surgery were enrolled in this retrospective cohort study. Evaluations were done every 3 months. RESULTS: Thirty-two patients enrolled in this study. Median follow up time was 23 months (Reverse Kaplan-Meier method). The rates of 1-year survival, 2-year survival, 3-year survival, 4-year survival, and 5-year survival were 75%, 52%, 52%, 37%, and 37%, respectively. No local recurrences occurred among patients; however, four patients experienced distal recurrence in the following locations: two cases (6.3%) in the liver, one case (3.1%) in the lung, and one case (3.1%) in the peritoneum. The rate of complete pathologic response (T0N0) was 21.9%. CONCLUSIONS: Neoadjuvant chemoradiation in patients with locally advanced GEJ and cardia adenocarcinoma will lead to a survival benefit.


Subject(s)
Adenocarcinoma/therapy , Chemoradiotherapy/methods , Esophageal Neoplasms/therapy , Neoadjuvant Therapy/methods , Neoplasm Recurrence, Local/epidemiology , Stomach Neoplasms/therapy , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Cardia/drug effects , Cardia/pathology , Cardia/radiation effects , Cardia/surgery , Disease-Free Survival , Esophageal Mucosa/drug effects , Esophageal Mucosa/pathology , Esophageal Mucosa/radiation effects , Esophageal Mucosa/surgery , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Esophagectomy , Esophagogastric Junction/drug effects , Esophagogastric Junction/pathology , Esophagogastric Junction/radiation effects , Esophagogastric Junction/surgery , Female , Follow-Up Studies , Gastrectomy , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Gastric Mucosa/radiation effects , Gastric Mucosa/surgery , Humans , Iran/epidemiology , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/prevention & control , Neoplasm Staging , Retrospective Studies , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Survival Rate
4.
World J Surg Oncol ; 13: 98, 2015 Mar 11.
Article in English | MEDLINE | ID: mdl-25885408

ABSTRACT

BACKGROUND: Pancreatic cancer is generally found in the older population Pancreaticoduodenectomy seems to be the only way in resolving these resectable tumors. Allen. O Whipple was the first to describe pancreaticoduodenectomy in 1935 as a modified procedure. This article is a case series with respect to the 7-year experience of the Whipple procedure in Firoozgar Teaching Hospital. METHODS: Patient surgery details were gathered from the surgical records of the operating room and their clinical records from the hospital archives. Data was analyzed with SPSS software (version 16.0.1). Those patients, whose tumor had invaded the superior mesenteric artery, had extensive portal vein involvement or distant metastasis was considered as unresectable. RESULTS: The first Whipple procedure was recorded in our hospital in 2008. From 2008 till 20 March 2014, 70 cases were collected and analyzed. The mean age of cases was 58.4 years, the mean hospital stay length was 12.9 days (±6.23 days), mean operation time was 376 min (±37.3 min),. The most common presenting symptom was jaundice (78.6 %). Delayed gastric emptying was the most common post-operative complication. The most prevalent cause of reoperation was intra-abdominal abscess. Major morbidities of these patients consisted of cardiac arrhythmias (21.4%) and pneumonia (10%). Minor complications were wound infection (17.1%) and delayed gastric emptying (32.9%). The statistics revealed pancreatic anastomosis failure as 2.9% and a decrease in mortality rate from 50% during the first years of this study to 16% to 20% during the last years. CONCLUSIONS: In this case series, the time of operation decreased during the recent years .Analysis shows a correlation between operation time and pack cell transfused during the operation, but no correlation was found between operation time and post-operation hospitalization course. It is true that hospital setting, socioeconomic level of the patients including their compliance, and the expertise of the surgeons and surgical staff can have an influence on the result of this operation, but it seems that the magnitude of the surgical stress of this procedure and the (compromised) functional reserve of this patient population can be a notable factor influencing the outcome.


Subject(s)
Biliary Tract Diseases/surgery , Liver Diseases/surgery , Pancreatic Diseases/surgery , Pancreaticoduodenectomy/mortality , Patient Readmission/statistics & numerical data , Postoperative Complications , Adult , Aged , Biliary Tract Diseases/mortality , Biliary Tract Diseases/pathology , Female , Follow-Up Studies , Humans , Length of Stay , Liver Diseases/mortality , Liver Diseases/pathology , Male , Middle Aged , Neoplasm Staging , Pancreatic Diseases/mortality , Pancreatic Diseases/pathology , Prognosis , Referral and Consultation , Reoperation , Survival Rate , Time Factors
5.
Ann Coloproctol ; 30(6): 285-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25580416

ABSTRACT

A barium enema is a diagnostic and therapeutic procedure commonly used for colon and rectum problems. Rectal perforation with extensive intra- and/or extraperitoneal spillage of barium is a devastating complication of a barium enema that leads to a significant increase in patient mortality. Due to the low number of reported cases in recent scientific literature and the lack of experience with the management of these cases, we would like to present our treatment approach to a rare case of retroperitoneal contamination with barium, followed by its intraperitoneal involvement during a diagnostic barium enema. Our experience with long-term management of the patient and the good outcome will be depicted in this paper.

SELECTION OF CITATIONS
SEARCH DETAIL
...